Alison Hogan

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

Martin Dennis, Gillian Mead, John Forbes et al. · The Lancet · 2018 · 276 citations · Full text

CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia

Kelly L. Williams, Simon Topp, Shu Yang et al. · Nature Communications · 2016 · 205 citations · Full text

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, Shuo Feng, Leila Janani et al. · The Lancet Infectious Diseases · 2022 · 170 citations · Full text

A Tol2 Gateway-Compatible Toolbox for the Study of the Nervous System and Neurodegenerative Disease

Emily K. Don, Isabel Formella, Andrew P. Badrock et al. · Zebrafish · 2016 · 83 citations

Engineering, Disease Progression, Neurochemical Biomarkers +17

Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord

Benjamin G. Trist, Sian Genoud, Stéphane Roudeau et al. · Brain · 2022 · 70 citations · Full text